Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Jeremy Levin
Fierce Biotech
Biotech leaders back FDA against ‘malicious’ abortion lawsuit
In the new amicus brief, the chief concern for the biotech industry is not mifepristone access per se, but the precedent the case could set.
Darren Incorvaia
Jul 22, 2026 9:00am
BMS channels $15B for share buybacks
Dec 13, 2021 10:11am
Industry veteran Jeremy Levin calls out pharma's buybacks
Jun 6, 2018 12:01pm
As Israel strikes to protest layoffs, it’s déjà vu for Teva
Dec 18, 2017 12:14pm
Top exec bails as Teva slates 3K-plus job cuts in Israel
Dec 12, 2017 3:37pm
Teva moves to cut hundreds of manufacturing jobs in Israel
Jul 24, 2017 9:55am
